These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36608017)

  • 1. Federal and Statewide Coverage for Opioid-Sparing Chronic Pain Treatments.
    McKay M; Gorvine MM; Zaller N; Singh V; Goree J
    Pain Physician; 2022 Dec; 25(9):E1457-E1466. PubMed ID: 36608017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers.
    Heyward J; Jones CM; Compton WM; Lin DH; Losby JL; Murimi IB; Baldwin GT; Ballreich JM; Thomas DA; Bicket MC; Porter L; Tierce JC; Alexander GC
    JAMA Netw Open; 2018 Oct; 1(6):e183044. PubMed ID: 30646222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.
    Lin DH; Jones CM; Compton WM; Heyward J; Losby JL; Murimi IB; Baldwin GT; Ballreich JM; Thomas DA; Bicket M; Porter L; Tierce JC; Alexander GC
    JAMA Netw Open; 2018 Jun; 1(2):e180235. PubMed ID: 30646077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State variation in opioid treatment policies and opioid-related hospital readmissions.
    Blanchard J; Weiss AJ; Barrett ML; McDermott KW; Heslin KC
    BMC Health Serv Res; 2018 Dec; 18(1):971. PubMed ID: 30558595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a whole health model of care emphasizing complementary and integrative health on reducing opioid use among patients with chronic pain.
    Zeliadt SB; Douglas JH; Gelman H; Coggeshall S; Taylor SL; Kligler B; Bokhour BG
    BMC Health Serv Res; 2022 Aug; 22(1):1053. PubMed ID: 35978421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries.
    Rao T; Kiptanui Z; Dowell P; Triebwasser C; Alexander GC; Harris I
    JAMA Netw Open; 2020 Mar; 3(3):e200274. PubMed ID: 32119095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
    Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
    Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurer coverage of prostate cancer biomarkers.
    Brant A; Weinstein IC; Lewicki P; Zhu A; Johnson JP; Sze C; Shoag JE
    Urol Oncol; 2023 Jul; 41(7):324.e9-324.e12. PubMed ID: 37225635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coverage and Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care.
    Abraham AJ; Andrews CM; Harris SJ; Westlake MM; Grogan CM
    JAMA Health Forum; 2022 Nov; 3(11):e224001. PubMed ID: 36331441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of State Insurance Coverage for Nonpharmacologic Treatment of Low Back Pain as Recommended by the American College of Physicians Guidelines.
    Bonakdar R; Palanker D; Sweeney MM
    Glob Adv Health Med; 2019; 8():2164956119855629. PubMed ID: 31384512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scope of health insurance coverage of vitiligo treatments in the United States: Implications for health care outcomes and disparities in children of color.
    Blundell A; Sachar M; Gabel CK; Bercovitch LG
    Pediatr Dermatol; 2021 Nov; 38 Suppl 2():79-85. PubMed ID: 34272764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021.
    Clemans-Cope L; Lynch V; Payton M; Aarons J
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):49. PubMed ID: 35794626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies.
    Welch HJ; Kabnick L; Vasquez MA; Monahan DL; Lurie F; Jacobowitz G
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):453-459. PubMed ID: 28411715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Opioid Use Disorder Diagnosis With Use of Physical Therapy and Chiropractic Care Among Chronic Low Back Pain Patients: A Group-Based Trajectory Analysis.
    Moyo P; Merlin JS; George M; Shireman TI; Marshall BDL
    J Pain; 2024 Mar; 25(3):742-754. PubMed ID: 37820847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Use of Complementary and Alternative Therapies for Back Pain Following Statewide Medicaid Coverage Changes in Oregon.
    Choo EK; Charlesworth CJ; Gu Y; Livingston CJ; McConnell KJ
    J Gen Intern Med; 2021 Mar; 36(3):676-682. PubMed ID: 33443692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value-based interventional pain management: a review of medicare national and local coverage determination policies.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Singh V; Hirsch JA
    Pain Physician; 2013; 16(3):E145-80. PubMed ID: 23703416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.
    Grogan CM; Andrews C; Abraham A; Humphreys K; Pollack HA; Smith BT; Friedmann PD
    Health Aff (Millwood); 2016 Dec; 35(12):2289-2296. PubMed ID: 27920318
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.